Vitamin B2 and Cancer: A Fresh Avenue for Ferroptosis-Based Therapies

Vitamin B2, commonly known as riboflavin, is traditionally recognized as an essential nutrient. However, recent research reveals a more complex role for this vitamin, particularly in cancer cells. A growing body of evidence suggests that vitamin B2 metabolism can significantly influence a cell’s susceptibility to ferroptosis, a unique form of regulated cell death, opening potential new avenues for cancer therapies.

Understanding Ferroptosis: A New Target in Cancer Treatment

Controlled cell death is a fundamental biological process that eliminates damaged or dangerous cells. Ferroptosis, unlike the more well-known apoptosis, is characterized by iron-dependent oxidation reactions in cell membranes. When oxidized fatty acids accumulate and overwhelm the cell’s antioxidant defenses, the cell membrane loses stability, leading to cell death. ¹ This process is particularly relevant to cancer research because tumors often thrive in environments with high metabolic activity, oxygen radicals, and disrupted redox balance, making them vulnerable to ferroptosis.

The Role of Vitamin B2 and FSP1 in Ferroptosis Resistance

Vitamin B2 plays a crucial role in protecting cells from oxidative damage through its conversion into cofactors like FMN and FAD, essential for numerous redox reactions. ³ Researchers have identified a key protein, Ferroptosis Suppressor Protein 1 (FSP1), as a protective shield against ferroptosis. ¹ FSP1’s stability and function are directly linked to the availability of FAD, derived from vitamin B2.

Specifically, the enzyme riboflavin kinase (RFK) and flavin adenine dinucleotide (FAD) synthase are critical for converting vitamin B2 into FAD. ¹ FAD binding is essential for both FSP1 activity, and stability. A deficiency in FAD or mutations that disrupt FSP1-FAD binding trigger FSP1 degradation via the ubiquitin-proteasome pathway, involving the E3 ligase RNF8. ¹

How Cancer Cells Utilize Vitamin B2 for Survival

Tumors are under significant biochemical stress due to rapid division and high energy consumption, leading to increased production of reactive molecules that can damage cellular components. ² Cancer cells develop defense mechanisms to avoid ferroptosis, and vitamin B2 metabolism is a key component of this protection. By ensuring adequate FSP1 stability through FAD binding, cancer cells can evade iron-driven membrane damage.

Experimental Findings: Targeting Riboflavin Metabolism

Recent experiments using A375 and HT1080 cell lines demonstrated that disrupting riboflavin metabolism weakens the defense against ferroptosis. ³ By using genome editing to disable RFK or FLAD1 (enzymes involved in FAD production), researchers observed a significant decrease in FSP1 levels and increased sensitivity to GPX4 inhibitors, which induce ferroptosis. The bacterial compound roseoflavin, a riboflavin analogue, effectively triggered ferroptosis in these cells at low concentrations.

Future Directions and Therapeutic Potential

While these findings are promising, a direct therapeutic application is not yet available. Vitamin B2 is essential for healthy cells, making a blanket withdrawal of the vitamin unsafe. The most promising therapeutic strategy lies in specifically targeting the portion of the riboflavin metabolism that stabilizes FSP1 in cancer cells. ⁴

It’s essential to note that tumors exhibit significant biological diversity, and not all cancers rely on FSP1 to the same extent. Further research is needed to determine the extent to which this mechanism can be effectively targeted in different cancer types and to translate these findings from cell cultures to complex tissues.

Key Takeaways

• Vitamin B2 metabolism plays a critical role in protecting cancer cells from ferroptosis.
• FSP1 protein stability, dependent on FAD derived from vitamin B2, is a key factor in ferroptosis resistance.
• Targeting riboflavin metabolism could offer a novel therapeutic approach to induce ferroptosis in cancer cells.
• Further research is needed to validate these findings and develop effective therapies.

This research highlights a new vulnerability in tumor metabolism and provides a foundation for developing innovative cancer therapies that exploit the link between vitamin B2, FSP1, and ferroptosis.